Assignee
ABION INC
KR·20 granted patents·8 pending applications·3 citations·filing 2013–2023
Top patents by PatentIndex Score
28 records- 0180US11107552B2Data processing, analysis method of gene expression data to identify endogenous reference genesABION INC·Filed 2018·Granted Aug 31, 2021·1 cites·2 claims
- 0279US11464832B2Composition for treating or sensitizing interferon beta resistant cancer disease comprising cFLIP siRNAABION INC·Filed 2017·Granted Oct 11, 2022·1 cites·5 claims
- 0379US10304561B2Data processing, analysis method of gene expression data to identify endogenous reference genesABION INC·Filed 2017·Granted May 28, 2019·1 cites·2 claims
- 0478US12371437B2Method of preparing camsylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Jul 29, 2025·0 cites·5 claims
- 0576US12528817B2Method of inhibiting kinase by mesylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Jan 20, 2026·0 cites·6 claims
- 0673US12377132B2Method for treating or sensitizing interferon beta resistant cancer comprising cFLIP siRNAABION INC·Filed 2022·Granted Aug 5, 2025·0 cites·10 claims
- 0773US12275740B2Method of inhibiting kinase by camsylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Apr 15, 2025·0 cites·5 claims
- 0871US12084450B2Mesylate salts of triazolopyrazine derivativesABION INC·Filed 2022·Granted Sep 10, 2024·0 cites·17 claims
- 0967US11964979B2Camsylate salts of triazolopyrazine derivativesABION INC·Filed 2022·Granted Apr 23, 2024·0 cites·12 claims
- 1065US11111536B2Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cellsABION INC·Filed 2019·Granted Sep 7, 2021·0 cites·4 claims
- 1163US11987582B2Maleate salts of triazolopyrazine derivatives, compositions, methods of use, and processes of manufacturing the sameABION INC·Filed 2021·Granted May 21, 2024·0 cites·38 claims
- 1260US2025271434A1Method for predicting prognosis of breast cancer patient using ctc expressing c-metABION INC·Filed 2023·Application pending·0 cites
- 1358US10576158B2Immune conjugate having dendron conjugated to antibody and use thereofABION INC·Filed 2017·Granted Mar 3, 2020·0 cites·11 claims
- 1457US10472678B2Reagent for detecting cross contamination of PDX-model related with human and mouse, the kit comprising the same, and the method for the cross contamination detectionABION INC·Filed 2017·Granted Nov 12, 2019·0 cites·6 claims
- 1557US2025281576A1Prophylactic administration method against respiratory virus, comprising administering interferon-beta to potential respiratory virus-infected subjectABION INC·Filed 2022·Application pending·0 cites
- 1653US9719093B2Composition for treating cancer associated with HPV infectionABION INC·Filed 2013·Granted Aug 1, 2017·0 cites·3 claims
- 1753US2018153932A1METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOFABION INC·Filed 2017·Application pending·0 cites
- 1852US2023159605A1Human interferon-beta variant with double mutation and method for improving stability of human interferon-beta variantABION INC·Filed 2021·Application pending·0 cites
- 1951US12098198B2Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereofABION INC·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 2051US10538529B2Polymorphic forms of triazolopyrazine derivatives and method of preparing the sameABION INC·Filed 2018·Granted Jan 21, 2020·0 cites·30 claims
- 2151US2022259260A1Method for purifying diglycosylated interferon-beta proteinABION INC·Filed 2020·Application pending·0 cites
- 2251US2024058273A1Method for preparing pharmaceutical formulation of tablet containing trizolopyrazine derivative as an active ingredientABION INC·Filed 2021·Application pending·0 cites
- 2350US12582707B2In-vitro transcript MRNA and pharmaceutical composition comprising sameABION INC·Filed 2021·Granted Mar 24, 2026·0 cites·10 claims
- 2446US2017198291A1Composition for treating cancer associated with hpv infectionABION INC·Filed 2017·Application pending·0 cites
- 2540US11207411B2Stabilized preparation of interferon beta variantABION INC·Filed 2017·Granted Dec 28, 2021·0 cites·6 claims
- 2639US11759500B2PEGylated interferon-beta variantABION INC·Filed 2015·Granted Sep 19, 2023·0 cites·12 claims
- 2736US11286296B2Anti-human ninjurin-1 (NINJ-1) antibodies and methods for detecting human NINJ-1ABION INC·Filed 2017·Granted Mar 29, 2022·0 cites·8 claims
- 2832US2018135055A1Composition for cancer cell sensitization containing as active ingredient substance inhibiting expression of oncogene of hpv virusABION INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABION INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →